Evidence map›Paper›PMID 36170590›Full record

ArticleTissue engineering. Part A2022

Human Induced Pluripotent Stem Cell Encapsulation Geometry Impacts Three-Dimensional Developing Human Engineered Cardiac Tissue Functionality.

Morgan E Ellis, Bryana N Harris, Mohammadjafar Hashemi, B Justin Harvell, Michaela Z Bush, Emma E Hicks, Ferdous B Finklea, Eric M Wang, Ravikiran Nataraj, Nathan P Young and 2 more

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. 3D Bioprinting Functional Engineered Heart Tissues.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Morgan E EllisDepartment of Chemical Engineering, Auburn University, Auburn, Alabama, USA.
Bryana N HarrisDepartment of Chemical Engineering, Auburn University, Auburn, Alabama, USA.
Mohammadjafar HashemiDepartment of Chemical Engineering, Auburn University, Auburn, Alabama, USA.
B Justin HarvellDepartment of Chemical Engineering, Auburn University, Auburn, Alabama, USA.
Michaela Z BushDepartment of Chemical Engineering, Auburn University, Auburn, Alabama, USA.
Emma E HicksDepartment of Chemical Engineering, Auburn University, Auburn, Alabama, USA.
Ferdous B FinkleaDepartment of Chemical Engineering, Auburn University, Auburn, Alabama, USA.
Eric M WangDepartment of Chemical Engineering, Auburn University, Auburn, Alabama, USA.
Ravikiran NatarajDepartment of Chemical Engineering, Auburn University, Auburn, Alabama, USA.ORCID 0000-0002-1955-3145
Nathan P YoungDepartment of Chemical Engineering, Auburn University, Auburn, Alabama, USA.
Irene C TurnbullCardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Elizabeth A LipkeDepartment of Chemical Engineering, Auburn University, Auburn, Alabama, USA.
Auburn University · USIcahn School of Medicine at Mount Sinai · US

Funding

National Dissemination of I-Corps@NCATS: Accelerating Translation through CommercializationUL1TR003096 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUTIERREZ, ORLANDO M, KIMBERLY, ROBERT P. · 2019 to 2023
$43.6M
Training In Cardiovascular Physiology & PharmacologyT32HL007444 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ju Chen, Robert Scott Ross · 1985 to 2026
$11.1M
UCSD PRIDE Faculty Development Program in Cardiovascular SciencesR25HL145817 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Robert Scott Ross, Joann Trejo · 2019 to 2026
$3.3M
Harnessing the Benefits of Adult Stem Cell Exosomes for Enhancing Cardiac Contractile FunctionK01HL133424 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CAL Y MAYOR-TURNBULL, IRENE · 2016 to 2020
$701k
Defining the role of non-myocytes to achieve biologically relevant engineered myocardial tissuesR03HL154286 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CAL Y MAYOR-TURNBULL, IRENE · 2020 to 2021
$170k
NCATS NIH HHS UL1 TR003096NHLBI NIH HHS K01 HL133424NHLBI NIH HHS R03 HL154286NHLBI NIH HHS R25 HL145817NHLBI NIH HHS T32 HL007444
6 · The paper itself

Abstract

Cardiac tissue engineering has been working to alleviate the immense burden of cardiovascular disease for several decades. To improve cardiac tissue homogeneity and cardiomyocyte (CM) maturation, in this study, we investigated altering initial encapsulation geometry in a three-dimensional (3D) direct cardiac differentiation platform. Traditional engineered cardiac tissue production utilizes predifferentiated CMs to produce 3D cardiac tissue and often involves various cell selection and exogenous stimulation methods to promote CM maturation. Starting tissue formation directly with human induced pluripotent stem cells (hiPSCs), rather than predifferentiated CMs, simplifies the engineered cardiac tissue formation process, making it more applicable for widespread implementation and scale-up. In this study, hiPSCs were encapsulated in poly (ethylene glycol)-fibrinogen in three tissue geometries (disc-shaped microislands, squares, and rectangles) and subjected to established cardiac differentiation protocols. Resulting 3D engineered cardiac tissues (3D-ECTs) from each geometry displayed similar CM populations (∼65%) and gene expression over time. Notably, rectangular tissues displayed less tissue heterogeneity and suggested more advanced features of maturing CMs, including myofibrillar alignment and Z-line formation. In addition, rectangular tissue showed significantly higher anisotropic contractile properties compared to square and microisland tissues (MI 0.28 ± 0.03, SQ 0.35 ± 0.05, RT 0.79 ± 0.04). This study demonstrates a straightforward method for simplifying and improving 3D-ECT production without the use of exogenous mechanical or electrical pacing and has the potential to be utilized in bioprinting and drug testing applications. Impact statement Current methods for improving cardiac maturation postdifferentiation remain tedious and complex. In this study, we examined the impact of initial encapsulation geometry on improvement of three-dimensional engineered cardiac tissue (3D-ECT) production and postdifferentiation maturation for three tissue geometries, including disc-shaped microislands, squares, and rectangles. Notably, rectangular 3D-ECTs displayed less tissue heterogeneity and more advanced features of maturing cardiomyocytes, including myofibrillar alignment, Z-line formation, and anisotropic contractile properties, compared to microisland and square tissues. This study demonstrates an initial human induced pluripotent stem cell-encapsulated rectangular tissue geometry can improve cardiac maturation, rather than implementing cell selection or tedious postdifferentiation manipulation, including exogenous mechanical and/or electrical pacing.

Indexed as

Induced Pluripotent Stem CellsCell DifferentiationHumansMyocardiumMyocytes, CardiacTissue Engineeringcardiac differentiationengineered heart tissuehuman induced pluripotent stem cellstissue geometry

Identifiers

PMID36170590
PMCPMC9807282
OpenAlexW4297516133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.